Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06161727
What this trial is testing

Detection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Treatment With IVF/ICSI.

Who this might be right for
Human Papilloma VirusInfertility, Male
Vastra Gotaland Region 260
Testing effectiveness (Phase 2)UnknownNCT05066646
What this trial is testing

A Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma (FUMANBA-1)

Who this might be right for
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 132
Not applicableUnknownNCT03078686
What this trial is testing

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

Who this might be right for
Alopecia AreataScarring Alopecia
Regeneris Medical 60
Large-scale testing (Phase 3)Study completedNCT00587405
What this trial is testing

Cyrotherapy vs. APC in GAVE

Who this might be right for
Watermelon Stomach
Mayo Clinic 60
Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Early research (Phase 1)Active Not RecruitingNCT04722146
What this trial is testing

Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 140
Testing effectiveness (Phase 2)Study completedNCT01029054
What this trial is testing

Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 53
Testing effectiveness (Phase 2)Temporarily pausedNCT06876142
What this trial is testing

Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma (RRMM)
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)UnknownNCT04009473
What this trial is testing

Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation

Who this might be right for
MenopauseMenopause Ovarian FailureOvarian Failure+21 more
Forever Young d.o.o. 100
Early research (Phase 1)WithdrawnNCT02561520
What this trial is testing

Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD

Who this might be right for
Graft-versus-host Disease
Ladan Espandar
Not applicableStudy completedNCT06404424
What this trial is testing

Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock

Who this might be right for
SepsisSeptic Shock
Efferon JSC 82
Large-scale testing (Phase 3)Study completedNCT04093583
What this trial is testing

Randomized Clinical Trial, Conventional Treatment-controlled, Studying the Efficacy of Plasma Rich in Growth Factor (PRGF®) in Alveolar Ridge Preservation After Simple Exodontia in the Anterior Region of Maxilla.

Who this might be right for
Dental Implantation
Fundación Eduardo Anitua 46
Not applicableStudy completedNCT01472627
What this trial is testing

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 11
Not applicableUnknownNCT02797041
What this trial is testing

Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.

Who this might be right for
Multiple Myeloma
IRCCS Centro di Riferimento Oncologico della Basilicata 100
Testing effectiveness (Phase 2)WithdrawnNCT01660997
What this trial is testing

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Not applicableNot Yet RecruitingNCT07289087
What this trial is testing

Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy

Who this might be right for
Quality of LifePatient Reported Outcome (PRO)Allogeneic Blood and Marrow Transplantation (BMT)+1 more
Associazione Qol-one 162
Large-scale testing (Phase 3)Study completedNCT01324947
What this trial is testing

Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 74
Not applicableEnded earlyNCT00313092
What this trial is testing

Obstructive Sleep Apnea Syndrome in Glaucoma

Who this might be right for
Obstructive Sleep Apnea SyndromeGlaucoma
Selim Orguel 60
Testing effectiveness (Phase 2)Study completedNCT00113932
What this trial is testing

UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 140
Next Page